4'-(4-Hydroxyphenyl)-2,2':6',2''-terpyridine, 97%, 1g

4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}benzohydrazide, 5g

Methyl 3-carbamimidoylbenzoate hydrochloride, 1g

2-Bromo-3-iodotoluene, 98.0%, 25g

1-BENZYL-3-HYDROXYMETHYL-PYRROLIDINE-3-CARBONITRILE, 95.0%, 2g

N-(2,6-Dimethylphenyl)-2-(2-oxopyrrolidin-1-yl)acetamide, 95.0%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3'-chloro-[1,1'-biphenyl]-4-yl)propanoic acid, 97%, 250mg

4-hydrazino-1-methylpiperidine dihydrochloride, 95.0%, 250mg

2-(7-Methoxy-2-oxo-2H-chromen-4-yl)acetic acid, 95.0%, 100g

2-(1,1,2,2-Tetrafluoro-ethoxy)-phenol, 95.0%, 25g

4-(4-Fluorophenyl)oxazole, 95+%, 250mg

1-Methyl-3-propyl-imidazolium iodide, min. 98%, 100 g, glass packaging

TRANS-4-(4-PYRIDINYL)-PYRROLIDINE-3-CARBOXYLIC ACID 2HCL, 95.0%, 250mg